In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Anti-Angiogenic Factor Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Identifies Patients at Risk for Severe Cerebral Vasospasm the First Day After Aneurysmal Subarachnoid Hemorrhage

    Final Number:
    556

    Authors:
    Christoph Johannes Griessenauer MD; Michelle Hui Juan Chua MD; Khalid Hanafy; Yaw Tachie Baffour; Aeryn Chen; Robert LeBlanc; Apar S Patel MD MPH; Mohamed Salem MD; Ananth Karumanchi; Christopher S. Ogilvy MD; Ajith J. Thomas MD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: The molecular mechanisms underlying cerebral vasospasm and delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) are incompletely understood. We hypothesized that anti-angiogenic factors, such as soluble Fms-like tyrosine kinase-1 (sFlt-1) and soluble transforming growth factor ß (TGFß) co-receptor endoglin (sEng), are important contributors to their pathophysiology.

    Methods: We performed a prospective study in aSAH patients and measured cerebrospinal fluid (CSF) and serum levels of sFlt-1 and sEng on post-bleed day 1 and 6 and correlated levels with incidence and severity of cerebral vasospasm and DCI.

    Results: Twenty-seven patients were enrolled in the study. Severe angiographic vasospasm was present in 14.8% of patients and DCI occurred in 33.3%. Elevated serum sFlt-1 on post-bleed day 1 was found to predict the development of severe angiographic vasospasm with an area under the curve (AUC) of 0.818 at marginal significance (p = 0.0578). A serum level of sFlt-1 on post-bleed day 1 of greater than 90 pg/mL had a AUC of 0.75 to predict severe angiographic vasospasm.

    Conclusions: Serum levels of sFlt1 are elevated in patients with aSAH who are at risk for vasospasm. Further studies with larger sample sizes are needed to evaluate whether sFlt1 levels may predict severe vasospasm.

    Patient Care: This research may help identify patients at greater risk for vasospasm early at the time of admission.

    Learning Objectives: By the conclusion of this session, participants should be able to describe the importance of anti-angiogenic factors in vasospasm from aneurysmal subarachnoid hemorrhage.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy